Two Sigma Securities, LLC Novavax Inc Put Options Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $1.04 Million - $2.16 Million	-28,700 Reduced 37.08%	48,700 $2.51 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $5.27 Million - $10.8 Million	75,600 Added 4200.0%	77,400 $5.7 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $753,536 - $1.22 Million	-5,600 Reduced 75.68%	1,800 $258,000
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $924,560 - $1.41 Million	5,200 Added 236.36%	7,400 $1.53 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $266,200 - $566,874	2,200 New	2,200 $467,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.